Which Is the Better Small-Cap ETF, Schwab's SCHA or iShares' IJR?

Schwab’s U.S. Small-Cap ETF (SCHA) offers broader small-cap exposure with 1,727 holdings vs. iShares’ 652 names in IJR, while cutting the expense ratio to 0.03% (down from 0.04% in June) versus 0.06% for IJR. Performance over the prior year is strong for both—29.90% for IJR vs. 34.20% for SCHA—with similar trailing dividend yields (~1.10% vs. 1.00%). The article frames SCHA as the more cost-effective, more tech/healthcare-tilted option, with trade-offs in volatility (5-year max drawdown: -30.80% vs. -28.00%).

Analysis

The meaningful distinction is factor loadout, not the fee gap. SCHA is the more aggressive small-cap beta vehicle: broader breadth, more tech/healthcare, and therefore more sensitivity to falling rates, easier credit, and a market that rewards speculative growth over balance-sheet quality. IJR is the cleaner “survivor” basket; if financing conditions tighten, its profitability screen should preserve relative performance and attract the kind of institutional flows that care more about implementation quality than 3 bps of fees.

The second-order effect is that SCHA can outperform sharply in a broadening rally, but it is also the more fragile wrapper if spreads widen or recession odds rise. That makes the fee reduction mainly a retail/RIA gathering tool, while the larger AUM/liquidity moat still matters for active allocators and anyone crossing size. Over 1-3 months, the critical question is whether small-cap leadership broadens beyond a handful of growth names; if not, the cheaper fund may underdeliver versus the more selective index despite lower carry cost.

Contrarian view: the market may be overweighting expense ratio and underweighting tradability and factor composition. For a multi-quarter hold, the bigger edge is choosing between quality and convexity, not between 3 and 6 bps. The thesis is falsified if credit stress emerges or if small-cap earnings revisions roll over; in that case, IJR should defend better and SCHA’s higher-beta mix should de-rate faster.

Key Decisions for Investors

• Long SCHA / short IJR for 3-6 months if the macro desk expects lower rates and a broadening small-cap rally; use it as a relative-value expression on beta, not on fee savings. Falsify the trade if credit spreads widen materially or IJR starts outpacing SCHA on a sustained basis.
• Prefer IJR over SCHA for defensive small-cap exposure into earnings season if you expect weaker revisions or tighter financial conditions. The risk/reward is better on the downside because the profitability filter should reduce drawdown versus the broader basket.
• If you only want one core small-cap sleeve for a 2-5 year horizon, use SCHA for maximal breadth; if you are tactically trading the segment, use IJR for liquidity and cleaner implementation. The expected edge is modest, so size accordingly.
• Set a watch item on small-cap credit sensitivity: if high-yield spreads or financing conditions deteriorate, rotate out of SCHA first. That would be the earliest signal that the broader, more tech-leaning basket is losing its factor tailwind.